I am the CCO of Champions Oncology, a technology-enabled research services provider. I also serve as the CEO of Corellia, a biotech that launched out of Champions Oncology leveraging AI-driven drug discovery to create transformative first-in-class oncology therapeutics. I have over 15 years of experience in the oncology sector, with a background in biochemistry, research, and business. I hold an MBA from NYU Stern and a PhD from Temple University.My mission is to drive the transformation of oncology therapeutic development by harnessing the power of data, science, and collaboration. As the CCO of Champions Oncology, I have led the organization to profitability and successfully restructured the company from a single service CRO to an enterprise with three independent business units. I founded and launched Corellia AI as a new entity, with a strong team building first-in-class therapeutics. I am passionate about advancing the field of oncology and delivering better outcomes for patients.
Listed skills include Biotechnology, Life Sciences, Tissue Culture, Antibodies, and 43 others.